Literature DB >> 20620091

Bent spine syndrome (camptocormia): a retrospective study of 63 patients.

Michel Laroche1, Pascal Cintas.   

Abstract

OBJECTIVES: Bent spine syndrome (BSS) is characterized by involuntary forward flexion of the trunk in the standing position but not in the recumbent position. We assessed the causes of BSS based on findings in 63 patients.
METHODS: We retrospectively reviewed the records of all patients with BSS evaluated at a teaching hospital in Toulouse, France, between 1995 and 2006. For each patient, we recorded the findings from the following investigations: physical examination, electromyogram (EMG), creatine phosphokinase (CPK) assay, computed tomography (CT), and surgical muscle biopsy.
RESULTS: We identified 63 patients, 46 females and 17 males, with a mean age of 70 ± 6.9 years. Among them, 40 had delayed-onset paraspinal myopathy, with fatty infiltration predominantly affecting the paraspinal muscles. In 40% of these patients, CT disclosed mild fatty infiltration of the gluteal and posterior thigh and leg muscles in addition to the paraspinal muscle abnormalities. Paraspinal muscle histology showed lobular endomysial fibrosis, as previously described and ruled out other forms of muscle dystrophy. The remaining 23 patients (14 females and nine males) had either another neurological disease or myopathic involvement of other muscles, with a definite diagnosis; nevertheless, forward bending of the trunk was the most prominent symptom and the reason for the initial physician visit.
CONCLUSION: In our case-series, delayed-onset paraspinal myopathy accounted for 64% of cases of BSS. The most informative investigation was CT, which showed a patchy decrease in paraspinal muscle density.
Copyright © 2010. Published by Elsevier SAS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20620091     DOI: 10.1016/j.jbspin.2010.05.012

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  7 in total

Review 1.  Camptocormia in Parkinson's disease: definition, epidemiology, pathogenesis and treatment modalities.

Authors:  Prachaya Srivanitchapoom; Mark Hallett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-04-20       Impact factor: 10.154

2.  Camptocormia as a clinical manifestation of polymyositis/systemic sclerosis overlap myositis associated with anti-Ku.

Authors:  Thierry Zenone; Nathalie Streichenberger; Marie Puget
Journal:  Rheumatol Int       Date:  2012-03-28       Impact factor: 2.631

3.  A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene.

Authors:  Sissel Løseth; Nicol C Voermans; Torberg Torbergsen; Sue Lillis; Christoffer Jonsrud; Sigurd Lindal; Erik-Jan Kamsteeg; Martin Lammens; Marcus Broman; Gabriele Dekomien; Paul Maddison; Francesco Muntoni; Caroline Sewry; Aleksandar Radunovic; Marianne de Visser; Volker Straub; Baziel van Engelen; Heinz Jungbluth
Journal:  J Neurol       Date:  2013-01-18       Impact factor: 4.849

4.  Design Method to Structure Orthosis Design: Camptocormia Postural Brace Case Study.

Authors:  Ricardo Duarte; Jean-Pierre Nadeau; Antonio Ramos; Michel Mesnard
Journal:  J Healthc Eng       Date:  2019-02-03       Impact factor: 2.682

5.  Camptocormia as the presenting symptom in sporadic late onset nemaline myopathy: a case report.

Authors:  Matthias Türk; Armin M Nagel; Frank Roemer; Ursula Schlötzer-Schrehardt; Christian T Thiel; Martin Winterholler; Rolf Schröder
Journal:  BMC Musculoskelet Disord       Date:  2019-11-20       Impact factor: 2.362

Review 6.  Camptocormia: Etiology, diagnosis, and treatment response.

Authors:  Farwa Ali; Joseph Y Matsumoto; Anhar Hassan
Journal:  Neurol Clin Pract       Date:  2018-06

Review 7.  Pathophysiological Concepts and Treatment of Camptocormia.

Authors:  N G Margraf; A Wrede; G Deuschl; W J Schulz-Schaeffer
Journal:  J Parkinsons Dis       Date:  2016-06-16       Impact factor: 5.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.